Skip to main content
. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691

Figure A.3.

Figure A.3

Schematic representation of CI and proposed inhibition binding sites by inhibitors of class A, B and C. Nicotinamide adenine dinucleotide (NADH, reduced and NAD, oxidised), flavin mononucleotide (FMN) and ubiquinone (Q) (Haefeli et al., 2012, fig. 46, CC‐BY‐ND)